Downregulation of microvascular endothelial type B endothelin receptor is a central vascular mechanism in hypertensive pregnancy

Hypertension

Volumn 64, Issue 3, 2014, Pages 632-643

  Mazzuca, Marc Q ^a   Li, Wei ^a   Reslan, Ossama M ^a   Yu, Peng ^a   Mata, Karina M ^a   Khalil, Raouf A ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Calcium; Endothelins; Hypertension; Nitric oxide; Pre eclampsia

Indexed keywords

CALCIUM ION; CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; ENDOTHELIN B RECEPTOR; N (2,6 DIMETHYLPIPERIDINOCARBONYL) 4 METHYLLEUCYL DEXTRO (1 METHOXYCARBONYLTRYPTOPHANYL) DEXTRO NORLEUCINE; N(G) NITROARGININE METHYL ESTER; NITRATE; NITRIC OXIDE; NITRITE; POTASSIUM CHLORIDE; SARAFOTOXIN S6C; SUCCINYLENDOTHELIN 1 [8-21][9 GLUTAMIC ACID 11,15 ALANINE];

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY DIAMETER; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; DISEASE MODEL; FEMALE; IMMUNOHISTOCHEMISTRY; MESENTERIC ARTERY; MICROVASCULATURE; NONHUMAN; PERFUSION PRESSURE; PLACENTA CIRCULATION; PREECLAMPSIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; RAT MODEL; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM; VASOCONSTRICTION; VASODILATATION; WESTERN BLOTTING;

CALCIUM; ENDOTHELINS; HYPERTENSION; NITRIC OXIDE; PRE-ECLAMPSIA;

ANIMALS; BLOOD PRESSURE; DOWN-REGULATION; ENDOTHELINS; ENDOTHELIUM, VASCULAR; FEMALE; HYPERTENSION, PREGNANCY-INDUCED; MICROVESSELS; OLIGOPEPTIDES; PEPTIDE FRAGMENTS; PEPTIDES, CYCLIC; PIPERIDINES; PREGNANCY; PREGNANCY, ANIMAL; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ENDOTHELIN B; VASOCONSTRICTION; VASODILATION; VIPER VENOMS;

EID: 84907598786     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.114.03315     Document Type: Article

References (43)

1. Thornburg KL, Jacobson SL, Giraud GD, Morton MJ. Hemodynamic changes in pregnancy. Semin Perinatol. 2000;24:11-14.
2. Uzan J, Carbonnel M, Piconne O, Asmar R, Ayoubi JM. Pre-eclampsia: pathophysiology, diagnosis, and management. Vasc Health Risk Manag. 2011;7:467-474.
3. George EM, Palei AC, Granger JP. Endothelin as a final common pathway in the path ophysiology of preeclampsia: Therapeutic implications. Curr Opin Nephrol Hypertens. 2012;21:157-162.
4. Khalil RA, Granger JP. Vascular mechanisms of increased arterial pressure in preeclampsia: lessons from animal models. Am J Physiol Regul Integr Comp Physiol. 2002;283:R29-R45.
5. Alexander BT. Fetal programming of hypertension. Am J Physiol Regul Integr Comp Physiol. 2006;290:R1-R10.
6. LaMarca B, Parrish M, Ray LF, Murphy SR, Roberts L, Glover P, Wallukat G, Wenzel K, Cockrell K, Martin JN Jr, Ryan MJ, Dechend R. Hypertension in response to autoantibodies to the angiotensin II type I receptor (AT1-AA) in pregnant rats: role of endothelin-1. Hypertension. 2009;54:905-909.
7. Davis JR, Giardina JB, Green GM, Alexander BT, Granger JP, Khalil RA. Reduced endothelial NO-cGMP vascular relaxation pathway during TN Falpha-induced hypertension in pregnant rats. Am J Physiol Regul Integr Comp Physiol. 2002;282:R390-R399.
8. Gilbert JS, Babcock SA, Granger JP. Hypertension produced by reduced uterine perfusion in pregnant rats is associated with increased soluble fm slike tyrosine kinase-1 expression. Hypertension. 2007;50:1142-1147.
9. Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF, Schisterman EF, Thadhani R, Sachs BP, Epstein FH, Sibai BM, Sukhatme VP, Karumanchi SA. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med. 2004;350:672-683.
10. Schiffrin EL. Vascular endothelin in hypertension. Vascul Pharmacol. 2005;43:19-29.
11. Sharma D, Singh A, Trivedi SS, Bhattacharjee J. Role of endothelin and inflammatory cytokines in pre-eclampsia-A pilot North Indian study. Am J Reprod Immunol. 2011;65:428-432.
12. Crews JK, Herrington JN, Granger JP, Khalil RA. Decreased endothelium-dependent vascular relaxation during reduction of uterine perfusion pressure in pregnant rat. Hypertension. 2000;35(1 pt 2):367-372.
13. Alexander BT, Rinewalt AN, Cockrell KL, Massey MB, Bennett WA, Granger JP. Endothelin type a receptor blockade attenuates the hypertension in response to chronic reductions in uterine perfusion pressure. Hypertension. 2001;37(2 pt 2):485-489.
14. Nakashima M, Vanhoutte PM. Endothelin-1 and-3 cause endotheliumdependent hyperpolarization in the rat mesenteric artery. Am J Physiol. 1993;265(6 pt 2):H2137-H2141.
15. Tirapelli CR, Casolari DA, Yogi A, Montezano AC, Tostes RC, Legros E, D'Orléans-Juste P, de Oliveira AM. Functional characterization and expression of endothelin receptors in rat carotid artery: Involvement of nitric oxide, a vasodilator prostanoid and the opening of K+ channels in ETB-induced relaxation. Br J Pharmacol. 2005;146:903-912.
16. Kelland NF, Kuc RE, McLean DL, Azfer A, Bagnall AJ, Gray GA, Gulliver-Sloan FH, Maguire JJ, Davenport AP, Kotelevtsev YV, Webb DJ. Endothelial cell-specific ETB receptor knockout: Autoradiographic and histological characterisation and crucial role in the clearance of endothelin-1. Can J Physiol Pharmacol. 2010;88:644-651.
17. Roberts L, LaMarca BB, Fournier L, Bain J, Cockrell K, Granger JP. Enhanced endothelin synthesis by endothelial cells exposed to sera from pregnant rats with decreased uterine perfusion. Hypertension. 2006;47:615-618.
18. Tam Tam KB, George E, Cockrell K, Arany M, Speed J, Martin JN Jr., Lamarca B, Granger JP. Endothelin type A receptor antagonist attenuates placental ischemia-induced hypertension and uterine vascular resistance. Am J Obstet Gynecol. 2011;204:330331-334.
19. Abdalvand A, Morton JS, Bourque SL, Quon AL, Davidge ST. Matrix metalloproteinase enhances big-endothelin-1 constriction in mesenteric vessels of pregnant rats with reduced uterine blood flow. Hypertension. 2013;61:488-493.
20. Mazzuca MQ, Dang Y, Khalil RA. Enhanced endothelin receptor type B-mediated vasodilation and underlying [Ca2+]i in mesenteric microvessels of pregnant rats. Br J Pharmacol. 2013;169:1335-1351.
21. Chen W, Khalil RA. Differential [Ca2+]i signaling of vasoconstriction in mesenteric microvessels of normal and reduced uterine perfusion pregnant rats. Am J Physiol Regul Integr Comp Physiol. 2008;295:R1962-R1972.
22. Ou M, Dang Y, Mazzuca MQ, Basile R, Khalil RA. Adaptive regulation of endothelin receptor type-A and type-B in vascular smooth muscle cells during pregnancy in rats. J Cell Physiol. 2014;229:489-501.
23. Roberts JM, Gammill HS. Preeclampsia: recent insights. Hypertension. 2005;46:1243-1249.
24. Zhou J, Xiao D, Hu Y, Wang Z, Paradis A, Mata-Greenwood E, Zhang L. Gestational hypoxia induces preeclampsia-like symptoms via heightened endothelin-1 signaling in pregnant rats. Hypertension. 2013;62:599-607.
25. D'Angelo G, Osol G. Regional variation in resistance artery diameter responses to alpha-adrenergic stimulation during pregnancy. Am J Physiol. 1993;264(1 pt 2):H78-H85.
26. Ramirez RJ, Debrah J, Novak J. Increased myogenic responses of resistance-sized mesenteric arteries after reduced uterine perfusion pressure in pregnant rats. Hypertens Pregnancy. 2011;30:45-57.
27. Neylon CB. Vascular biology of endothelin signal transduction. Clin Exp Pharmacol Physiol. 1999;26:149-153.
28. Schroeder AC, Imig JD, LeBlanc EA, Pham BT, Pollock DM, Inscho EW. Endothelin-mediated calcium signaling in preglomerular smooth muscle cells. Hypertension. 2000;35(1 pt 2):280-286.
29. Cain AE, Tanner DM, Khalil RA. Endothelin-1-induced enhancement of coronary smooth muscle contraction via MAPK-dependent and MAP Kindependent [Ca(2+)](i) sensitization pathways. Hypertension. 2002;39(2 pt 2):543-549.
30. Roberts-Thomson P, McRitchie RJ, Chalmers JP. Endothelin-1 causes a biphasic response in systemic vasculature and increases myocardial contractility in conscious rabbits. J Cardiovasc Pharmacol. 1994;24:100-107.
31. Matz RL, Van Overloop B, Gairard A. Hypotensive effect of endothelin-1 in nitric oxide-deprived, hypertensive pregnant rats. Am J Hypertens. 2001;14(6 pt 1):585-591.
32. Gariepy CE, Ohuchi T, Williams SC, Richardson JA, Yanagisawa M. Salt-sensitive hypertension in endothelin-B receptor-deficient rats. J Clin Invest. 2000;105:925-933.
33. Kohan DE, Rossi NF, Inscho EW, Pollock DM. Regulation of blood pressure and salt homeostasis by endothelin. Physiol Rev. 2011;91:1-77.
34. Schiffrin EL, Touyz RM. Vascular biology of endothelin. J Cardiovasc Pharmacol. 1998;32(suppl 3):S2-S13.
35. Mazzuca MQ, Khalil RA. Vascular endothelin receptor type B: structure, function and dysregulation in vascular disease. Biochem Pharmacol. 2012;84:147-162.
36. LaMarca BB, Cockrell K, Sullivan E, Bennett W, Granger JP. Role of endothelin in mediating tumor necrosis factor-induced hypertension in pregnant rats. Hypertension. 2005;46:82-86.
37. Walsh SK, English FA, Johns EJ, Kenny LC. Plasma-mediated vascular dysfunction in the reduced uterine perfusion pressure model of preeclampsia: A micro vascular characterization. Hypertension. 2009;54:345-351.
38. Félétou M, Vanhoutte PM. EDHF: An update. Clin Sci (Lond). 2009;117:139-155.
39. Madsen KM, Neerhof MG, Wessale JL, Thaete LG. Influence of ET(B) receptor antagonism on pregnancy outcome in rats. J Soc Gynecol Investig. 2001;8:239-244.
40. Bridges JP, Gilbert JS, Colson D, Gilbert SA, Dukes MP, Ryan MJ, Granger JP. Oxidative stress contributes to soluble fms-like tyrosine kinase-1 induced vascular dysfunction in pregnant rats. Am J Hypertens. 2009;22:564-568.
41. Murphy SR, LaMarca BB, Cockrell K, Granger JP. Role of endothelin in mediating soluble fms-like tyrosine kinase 1-induced hypertension in pregnant rats. Hypertension. 2010;55:394-398.
42. Wallukat G, Homuth V, Fischer T, Lindschau C, Horstkamp B, Jüpner A, Baur E, Nissen E, Vetter K, Neichel D, Dudenhausen JW, Haller H, Luft FC. Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor. J Clin Invest. 1999;103: 945-952.
43. Touyz RM, Deng LY, Schiffrin EL. Endothelin subtype B receptor-mediated calcium and contractile responses in small arteries of hypertensive rats. Hypertension. 1995;26(6 pt 2):1041-1045.